p53: Emergency brake and target for cancer therapy

Experimental Cell Research

Volumn 237, Issue 1, 1997, Pages 14-18

  Wiman, Klas G ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

APOPTOSIS; CARCINOGENESIS; GENE EXPRESSION REGULATION; GENE TARGETING; HUMAN; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; SHORT SURVEY; TUMOR SUPPRESSOR GENE;

EID: 0031586609     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1997.3834     Document Type: Article

References (39)

1. 1. Harris, C. C. (1993). p53: At the crossroads of molecular carcinogenesis and risk assessment. Science 262, 1980-1981.
2. 2. Greenblatt, M. S., Bennett, W. P., Hollstein, M., and Harris, C. C. (1994). Mutations in the p53 tumor suppressor gene: Clues to cancer etiology and molecular pathogenesis. Cancer Res. 54, 4855-4878.
3. 3. Ko, L. J., and Prives, C. (1996). p53: Puzzle and paradigm. Genes Dev. 10, 1054-1072.
4. 4. Selivanova, G., Iotsova, V., Kiseleva, E., Ström, M., Bakalkin, G., Grafström, R. C., and Wiman, K. G. (1996). The single stranded DNA end binding site of p53 coincides with the C-terminal regulatory region. Nucleic Acids Res. 24, 3560-3567.
5. 5. Hupp, T. R., Meek, D. W., Midgley, C. A., and Lane, D. P. (1992). Regulation of the specific DNA binding function of p53. Cell 71, 875-886.
6. 6. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. (1993). WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825.
7. 7. Sherr, C. J. (1996). Cancer cell cycles. Science 274, 1672-1677.
8. 8. Smith, M. L., Chen, I.-T., Zhan, Q., Bae, I., Chen, C.-Y., Gilmer, T. M., Kastan, M. B., O'Connor, P. M., and Fornace, A. J., Jr. (1994). Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science 266, 1376-1380.
9. 9. Buckbinder, L., Talbott, R., Velasco-Miguel, Takenaka, I., Faha, B., Seizinger, B. R., and Kley, N. (1995). Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377, 646-649.
10. 10. Miyashita, T., and Reed, J. C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
11. 11. Knudson, C. M., Tung, K. S. K., Tourtellotte, W. G., Brown, G. A. J., and Korsmeyer, S. J. (1995). Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99.
12. 12. Yin, C., Knudson, C. M., Korsmeyer, S. J., and Van Dyke, T. (1996). Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 385, 637-640.
13. 13. Owen-Schaub, L. B., Zhang, W., Cusack, J. C., Angelo, L. S., Santee, S. M., Fujiwara, T., Roth, J. A., Deisseroth, A. B., Zhang, W.-W., Kruzel, E., and Radinsky, R. (1995). Wild type human p53 and a temperature-sensitive mutant induce fas/ APO-1 expression. Mol. Cell. Biol. 15, 3032-3040.
14. 14. Israeli, D., Tessler, E., Haupt, Y., Elkeles, A., Wilder, S., Amson, R., Telerman, A., and Oren, M. (1997). A novel p53-inducible gene, PAG680, encodes a nuclear zinc finger protein whose overexpression promotes apoptosis. EMBO J. 16, 4384-4392.
15. 15. Varmeh-Ziaie, S., Okan, I., Wang, Y., Magnusson, K. P., Warthoe, P., Strauss, M., and Wiman, K. G. (1997). Wig-1, a new p53-induced gene encoding a zinc finger protein. Oncogene, in press.
16. 16. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., and Vogelstein, B. (1997). A model for p53-induced apoptosis. Nature 389, 300-305.
17. 17. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. (1991). Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352, 345-347.
18. 18. Canman, C. E., Gilmer, T. M., Coutts, S. B., and Kastan, M. B. (1995). Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev. 9, 600-611.
19. 19. Haupt, Y., Rowan, S., and Oren, M. (1995). p53-mediated apoptosis in HeLa cells can be overcome by excess pRB. Oncogene 10, 1563-1571.
20. 20. Polyak, K., Waldman, T., He, T.-C., Kinzler, K. W., and Vogelstein, B. (1996). Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10, 1945-1952.
21. 21. Chen, X., Ko, L. J., Jayaraman, L., and Prives, C. (1996). p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 10, 2438-2451.
22. 22. Walker, K. K., and Levine, A. J. (1996). Identification of a novel p53 functional domain that is necessary for efficient growth suppression. Proc. Natl. Acad. Sci. USA 93, 15335-15340.
23. 23. Sakamuro, D., Sabbatini, P., White, E., and Prendergast, G. C. (1997). The polyproline region of p53 is required to activate apoptosis but not growth arrest. Oncogene 15, 887-898.
24. 24. Wu, X., Bayle, H., Olson, D., and Levine, A. J. (1993). The p53-mdm2 autoregulatory loop. Genes Dev. 7, 1126-1132.
25. 25. Haupt, Y., Maya, R., Kazaz, A., and Oren, M. (1997). Mdm2 promotes the rapid degradation of p53. Nature 387, 296-299.
26. 26. Kubbutat, M. H. G., Jones, S. N., and Vousden, K. H. (1997). Regulation of p53 stability by Mdm2. Nature 387, 299-303.
27. 27. Halazonetis, T. D., Davis, L. J., and Kandil, A. N. (1993). Wild type p53 adopts a "mutant"-like conformation when bound to DNA. EMBO J. 12, 1021-1028.
28. 28. Takenaka, I., Morin, F., Seizinger, B. R., and Kley, N. (1995). Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270, 5405-5411.
29. 29. Hupp, T. R., Sparks, A., and Lane, D. P. (1995). Small peptides activate the latent sequence-specific DNA binding function of p53. Cell 83, 237-245.
30. 30. Selivanova, G., Iotsova, V., Okan, I., Pritsche, M., Ström, M., Groner, B., Grafström, R. C., and Wiman, K. G. (1997). Restoration of the growth suppression function of mutant p53 by a synthetic peptide derived from the p53 C-terminal domain. Nature Med. 3, 632-638.
31. 31. Gu, W., Shi, X.-L., and Roeder, R. G. (1997). Synergistic activation of transcription by CBP and p53. Nature 387, 819-823.
32. 32. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., and Livingston, D. M. (1997). Binding and modulation of p53 by p300/CBP coactivators. Nature 387, 823-827.
33. 33. Gu, W., and Roeder, R. G. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90, 595-606.
34. 34. Selivanova, G., and Wiman, K. G. (1995). p53: A cell cycle regulator activated by DNA damage. Adv. Cancer Res. 66, 143-180.
35. 35. Abarzua, P., LoSardo, J. E., Gubler, M. L., Spathis, R., Lu, Y.-A., Felix, A., and Neri, A. (1996). Restoration of the transcription activation function to mutant p53 in human cancer cells. Oncogene 13, 2477-2482.
36. 36. Kaghad, M., Bonnet, H., Yang, A., Creancier, L., Biscan, J.-C., Valent, A., Minthy, A., Chalon, P., Lelias, J.-M., Dumont, X., Ferrara, P., McKeon, F., and Caput, D. (1997). Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 90, 809-819.
37. 37. Jost, C. A., Marin, M. C., and Kaelin, W. G., Jr. (1997). p73 is a human p53-related protein that can induce apoptosis. Nature 389, 191-194.
38. 38. Lee, S., Elenbaas, B., Levine, A. J., and Griffith, J. (1995). p53 and its 14 kDa C-terminal domain recognize primary DNA damage in the form of insertion/deletion mismatches. Cell 81, 1013-1020.
39. 39. Okamoto, K., and Beach, D. (1994). Cyclin G is a transcriptional target of the p53 tumor suppressor protein. EMBO J. 13, 4816-4822.